Diabetic kidney disease affects a growing proportion of people with diabetes and remains the leading cause of end-stage renal ...

Janus Henderson reports the Triton Fund lagged its index while maintaining a cautious stance on market imbalances. Read more ...

An American Heart Association presidential advisory in 2023 introduced a new term: cardiovascular-kidney-metabolic syndrome.

The FDA has authorized Mayo Clinic to offer mesenchymal stem cells as part of the Regenerative Nephrology Compassionate Use Program. This is an expanded access program.

A conserved signaling axis linking Drosophila adipose tissue to nephrocyte function reveals how obesity can drive kidney dysfunction and points to new opportunities for therapeutic intervention.